/NEU
NEU
Updated 24 Aug 08:16 am
$22.45
NEUREN PHARMACEUTICALS LIMITED
1D-1.55%
1M+26.66%
1Y+14.78%
Track your position in NEU
Sign in to TradeLedgr to record trades in NEU (NEUREN PHARMACEUTICALS LIMITED) with broker-true precision and ATO-compliant reporting.
Recent Announcements
21 Aug 2026 5:19 AM
Neuren H1 2026 Financial Results Webinar on 26 August 2026163KB
Notification of Results/Reporting Date
04 Aug 2026 11:52 PM
Record Q2 DAYBUE net sales of US$125m, CY26 royalty upgraded255KB
Progress Report
23 Jul 2026 11:57 PM
Neuren highlights participation in PMSF Family Conference211KB
Company Administration - Other
28 Jun 2026 9:43 PM
DAYBU recommended for approval in the European Union200KB
Progress Report
18 Jun 2026 6:49 AM
Application for quotation of securities - NEU15KB
Appendix 2A
Fundamentals
P/E Ratio
99.42x
Div Yield
0.00%
EPS
$0.2328
Avg Vol
482K
52W High
$23.760
52W Low
$11.000
Company Profile
Biopharmaceutical company with a focus on neurological conditions.
Financial History
2025A
$30.4M profit
$76.8M rev
2024A
$142.0M profit
$224.3M rev
2023A
$157.1M profit
$237.6M rev